Nuveen’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
MA
BFM
CCM
PLC
Nuveen's MXCT Position: Q2 2026 in Review
Nuveen sold out of MaxCyte (MXCT) in Q2 2026, closing a stake of 218,497 shares — an estimated $153K sold.
Nuveen first reported a position in MXCT in Q3 2021 and held it in 19 quarters. The position peaked at $3.31M in Q4 2021. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.
- Nuveen reported no remaining MaxCyte position as of Q2 2026 after selling out during the quarter.
- Nuveen sold 218,497 MaxCyte shares in Q2 2026, an estimated $153K.
- Nuveen first reported a position in MaxCyte in Q3 2021 and held it in 19 quarters.
- Nuveen's MaxCyte position peaked at $3.31M in Q4 2021.
- 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.